Position in AZN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,528,939
-$345,850 QoQ
Shares Held
29,158
-2.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#383
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GLOBALT Investments LLC / GA holds $66,458,169 across 7 Drug Manufacturers - General names. AZN ranks #7 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,538 | $17,437,314 | |
| 2 | JNJ |
Johnson & Johnson
|
52,696 | $13,383,203 | |
| 3 | AMGN |
Amgen Inc
|
27,727 | $10,040,501 | |
| 4 | MRK |
Merck & Co., Inc.
|
56,795 | $7,298,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
53,145 | $6,714,339 | |
| 6 | ABBV |
AbbVie Inc.
|
24,065 | $6,055,716 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
29,158 | $5,528,939 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,528,939 | 29,158 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,874,789 | 29,788 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||